| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |